Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma. - Xu, Yong-Hua; Liu, Shuo-Hui; Hao, Fu-Rong; Zhang, Yin-Huan (Cancer Biomarkers, 2018)